Financial Architects (New Jersey)’s AMAG Pharmaceuticals AMAG Stock Holding History

Financial Architects (New Jersey)’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-200	Closed	-$3K	–	1647
2017 Q4	$3K	Hold	200	–	–	﹤0.01%	1391
2017 Q3	$4K	Sell	200 -100	-33%	-$1.86K	﹤0.01%	1341
2017 Q2	$6K	Buy	+300	New	+$5.95K	﹤0.01%	1259
2016 Q2	–	Sell	-23	Closed	-$1K	–	1505
2016 Q1	$1K	Buy	+23	New	+$546	﹤0.01%	1150
2015 Q3	–	Sell	-3,023	Closed	-$209K	–	1034
2015 Q2	$209K	Buy	+3,023	New	+$190K	0.08%	188

Other funds holding AMAG

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Financial Architects (New Jersey)'s AMAG Position: Q1 2018 in Review

Financial Architects (New Jersey) sold out of AMAG Pharmaceuticals (AMAG) in Q1 2018, closing a stake of 200 shares — an estimated $3K sold.

Financial Architects (New Jersey) first reported a position in AMAG in Q2 2015 and held it in 5 quarters. The position peaked at $209K in Q2 2015. 170 funds tracked by Wall St. Rank hold AMAG as of Q1 2018.

Financial Architects (New Jersey) reported no remaining AMAG Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Financial Architects (New Jersey) sold 200 AMAG Pharmaceuticals shares in Q1 2018, an estimated $3K.
Financial Architects (New Jersey) first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 5 quarters.
Financial Architects (New Jersey)'s AMAG Pharmaceuticals position peaked at $209K in Q2 2015.
170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2018.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2018, filed 23 Apr 2018.